4//SEC Filing
Grant Jeremy T 4
Accession 0001415889-23-016943
CIK 0001583107other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 6:09 PM ET
Size
10.8 KB
Accession
0001415889-23-016943
Insider Transaction Report
Form 4
Grant Jeremy T
Director
Transactions
- Award
Share Option (Right to Buy)
2023-12-21+6,578→ 6,578 totalExercise: $11.33Exp: 2033-12-21→ Ordinary Shares (6,578 underlying) - Award
Ordinary Shares
2023-12-21+8,826→ 8,826 total - Award
Ordinary Shares
2023-12-21+2,942→ 11,768 total - Award
Share Option (Right to Buy)
2023-12-21+19,734→ 19,734 totalExercise: $11.33Exp: 2033-12-21→ Ordinary Shares (19,734 underlying)
Footnotes (2)
- [F1]The option vests monthly over 24 months of service from the date of grant.
- [F2]This option shall vest monthly over four months of service from the date of grant and will vest in full upon earlier of the four-month anniversary of Jeremy Grant's appointment to the Board or the date of Company's 2024 annual meeting of Shareholders.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0002004368
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 6:09 PM ET
- Size
- 10.8 KB